HAVCR2 and melanoma: Nevertheless, it is possible that - if TIM-3 and LAG-3 present a reduced expression in immune cells that were exposed to the secretome of melanoma cells subjected to inflammatory conditions -, they might not be the most effective targets to be explored in the clinic.